Literature DB >> 10198161

Refined genetic and physical localization of the Wagner disease (WGN1) locus and the genes CRTL1 and CSPG2 to a 2- to 2.5-cM region of chromosome 5q14.3.

R Perveen1, N Hart-Holden, M J Dixon, W Wiszniewski, A E Fryer, H G Brunner, A J Pinkners, S E van Beersum, G C Black.   

Abstract

Wagner syndrome (WGN1; MIM 143200), an autosomal dominant vitreoretinopathy characterized by chorioretinal atrophy, cataract, and retinal detachment, is linked to 5q14.3. Other vitreoretinopathies without systemic stigmata, including erosive vitreoretinopathy, are also linked to this region and are likely to be allelic. Within the critical region lie genes encoding two extracellular macromolecules, link protein (CRTL1) and versican (CSPG2), which are important in binding hyaluronan, a significant component of the mammalian vitreous gel, and which therefore represent excellent candidates for Wagner syndrome. Genetic mapping presented here in two further families reduces the critical region to approximately 2 cM. Subsequent refinement of the physical map allows ordering of known polymorphic microsatellites and excludes CRTL1 as a likely candidate for the disorder. CSPG2 is shown to lie within the critical region; however, analysis of the complete coding region of the mature peptide reveals no clear evidence that it is the gene underlying WGN1. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198161     DOI: 10.1006/geno.1999.5766

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.

Authors:  Barbara Kloeckener-Gruissem; John Neidhardt; István Magyar; Henri Plauchu; Jean-Christophe Zech; Laurette Morlé; Sheila M Palmer-Smith; Moira J Macdonald; Véronique Nas; Andrew E Fry; Wolfgang Berger
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

2.  Clinical characterisation and molecular analysis of Wagner syndrome.

Authors:  Sarah P Meredith; Allan J Richards; Declan W Flanagan; John D Scott; Arabella V Poulson; Martin P Snead
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

3.  COL2A1 exon 2 mutations: relevance to the Stickler and Wagner syndromes.

Authors:  A J Richards; S Martin; J R Yates; J D Scott; D M Baguley; F M Pope; M P Snead
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

4.  Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.

Authors:  Shawn M Ronan; Khanh-Nhat Tran-Viet; Erica L Burner; Ravikanth Metlapally; Cynthia A Toth; Terri L Young
Journal:  Arch Ophthalmol       Date:  2009-11

5.  WAGNER syndrome: anatomic, functional and genetic characterization of a Portuguese family.

Authors:  Joana R Araújo; João Tavares-Ferreira; Sérgio Estrela-Silva; Paulo Rocha; Elisete Brandão; Pedro Alves Faria; Fernando Falcão-Reis; Amândio Rocha-Sousa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-25       Impact factor: 3.117

6.  The synthesis and secretion of versican isoform V3 by mammalian cells: A role for N-linked glycosylation.

Authors:  Ingrid A Harten; Gernot Kaber; Kiran J Agarwal; Inkyung Kang; Sean Reyes Ibarrientos; Gail Workman; Christina K Chan; Mary P Nivison; Nadine Nagy; Kathleen R Braun; Michael G Kinsella; Mervyn J Merrilees; Thomas N Wight
Journal:  Matrix Biol       Date:  2020-01-27       Impact factor: 11.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.